Get notified when TOXR files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • The Trust Agreement Restricts Shareholders' Ability to Bring Derivative Actions, Requiring Two Non-affiliated Shareholders Holding At Least 10% of Shares to Join and Meet Pre-suit Demand Procedures. (new) — This governance restriction makes shareholder derivative suits practically impossible due to the 10% ownership threshold and lack of coordination mechanisms.
CBOE: TOXR 21Shares XRP ETF 424B3

21Shares XRP ETF (TOXR) files 424B3; Q1 2026 net loss $52.3M as XRP price drops 26.5%

Filed May 14, 2026 · ~1 min read

Key Changes

  • high

    The Trust's NAV fell 42.6% in Q1 2026 to $142.1M, driven by a 26.5% drop in XRP price and net share redemptions of 3.04M shares.

    Management’s Discussion and Analysis verify on EDGAR →
  • high

    GAAP net loss for the quarter was $52.3M, primarily from unrealized depreciation on XRP and realized losses on redemptions.

    Management’s Discussion and Analysis verify on EDGAR →
  • medium

    Sponsor fee was reduced from 2.50% to 0.30% of NAV effective December 11, 2025, lowering ongoing costs for shareholders.

    Management’s Discussion and Analysis verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (MKC 10-Q) is open in full — no account needed.

Partner

Trade TOXR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify